US Dietary Supplement Industry In 2023: Little New Expected In NDI Notification Enforcement
Executive Summary
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight concludes series here reporting on supplement sector’s outlook for FDA potentially resolving its protracted struggle with NDI notification requirement.